A. Ugolini et al., Potentiation of NMDA and AMPA responses by the specific mGluR(5) agonist CHPG in spinal cord motoneurons, NEUROPHARM, 38(10), 1999, pp. 1569-1576
The specific metabotropic glutamate receptor (mGluR)(5) agonist (RS)-2-chlo
ro-5-hydroxyphenylglycine (CHPG) is able to potentiate NMDA and AMPA respon
ses recorded from ventral roots of the isolated hemisected baby rat spinal
cord. Previously we have demonstrated that activation of group I mGluRs (mG
luR(1) and mGluR(5)) with the broad spectrum mGluR agonist 1S,3R-1-amino-1,
3-cyclopentanedicarboxylate (ACPD) produced potentiation of ionotropic glut
amate responses. In contrast to ACPD-induced potentiation, however, no evid
ence for an involvement of protein kinase C (PKC) is found in the CHPG-indu
ced potentiation of both NMDA and AMPA depolarization because the PKC block
ers chelerythrine chloride or calphostin C did not antagonize this effect.
Moreover, in the absence of Ca2+ in the perfusing medium or depleting intra
cellular Ca2+ stores with thapsigargin or dantrolene did not modify the CHP
G-induced enhancement of NMDA depolarizations. Phorbol-12,13-diacetate (PDA
), on the other hand, was able to attenuate this effect, which was reversed
by chelerythrine chloride. These results suggest that both mGluR(5) and mG
luR(1) may act to enhance ionotropic glutamate responses but the two types
of mGluRs may have different intracellular mechanisms of action. (C) 1999 E
lsevier Science Ltd. All rights reserved.